Go to content
Go to search
Go to menu

Newsroom
Publications
Press room
Participant area

Français
English

Submit a project

Who are we?
Who are we? ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases. Découvrir la rubrique

The agency in brief A central role in infectious diseases research for over 35 years

Mission and strategy Supporting research to prevent, understand and treat infectious diseases

Facilitating, funding and structuring research ANRS MIE three majors levels of action

Organisation and governance ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.

Scientific commitments and values Patient associations, next generation of scientists, quality and ethical approach, open science
Research
Research Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases. Découvrir la rubrique

Diseases and pathogens Learn more about the diseases and pathogens covered by our research

Research projects Information on the projects we fund

Scientific facilitation groups Our workgroups bring together researchers and representatives of civil society

Innovation Committee Guiding and advising innovative project leaders
Infrastructures
Infrastructures The agency supports a number of research platforms and networks to federate and help shape research in its field Découvrir la rubrique

Research platforms National and international research platforms supported by the agency and designed for the scientific community

Thematic networks Clinical research networks and networks of young researchers

Data and samples Access to data and biological collections from research promoted by the agency
Partnerships
Partnerships The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives Découvrir la rubrique

The ANRS MIE International Network Partner sites, international global health research platforms, ad hoc partnerships

Partnerships and initiatives WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks

International structuring projects Strategic international projects and capacity-building programmes

WHO filovirus CORC Fighting epidemics: ANRS MIE leads WHO filovirus CORC

Patient associations Collaboration with community stakeholders
Funding
Funding Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players Découvrir la rubrique

All calls for proposals Agency's current, forthcoming and completed calls for proposals

Winning projects and candidates Find out the list of calls for projects previously funded by the agency

The ANRS Emerging infectious diseases Start programme Find out the Start programme, here to support and guide the next generation of scientific researchers
Disease Outbreak
Disease Outbreak ANRS MIE is at the forefront of crisis preparedness and response. Découvrir la rubrique

Outbreak Response programme Facilitation and watch procedure for responding to emerging or re-emerging epidemics.

Filovirus (Ebola) Outbreak Response Unit This Outbreak Response Unit for several diseases is active since March 2025.

Influenza/Flu Outbreak Response unit ANRS MIE continues to follow influenza closely since June 2024.

Chikungunya Outbreak Response Unit Opened since January 2025 and still active since the detection of one new case in French Guiana in January 2026.

Outbreak Response units Every Outbreak response units, active or inactive.

Newsroom
Publications
Press room
Participant area
- Français
- English

Submit a project

Search

Homepage
Publications
The Senegalese initiative for access to antiretroviral drugs

The Senegalese initiative for access to antiretroviral drugs (in French)

Economic, social, behavioral and medical analyses

Last updated on 29 November 2023

Share:

Share on Twitter
Share on Linkedin

AIDS, immigration and inequalities: new realities, new challenges

Economics of aids and access to hiv/aids care in developing countries. Issues and challenges

Pratical information

Newsroom
Contact us
Join us
Site map

Legal

Legal information
Personal data and cookies
Accessibility